| H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
| PES1 |
PES1: Pescadillo homolog 1 |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRAP |
GRAP: GRB2-related adapter protein |
4.09 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
4.09 |
Evidence |
|
| HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
TAF13 |
TAF13, TAF2K, TAFII18: Transcription initiation factor TFIID subunit 13 |
4.085 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
4.085 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
4.085 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
4.085 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
ADRA2A |
IPI00031712 |
4.085 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
4.085 |
Evidence |
|
| BMP6 |
BMP6, VGR: Bone morphogenetic protein 6 precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
4.085 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
HHEX |
HHEX, HEX, PRH, PRHX: Homeobox protein PRH |
4.085 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
4.085 |
Evidence |
|
| BMP2 |
BMP2, BMP2A: Bone morphogenetic protein 2 precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
4.085 |
Evidence |
|
| INHBB |
INHBB: Inhibin beta B chain precursor |
BMP6 |
BMP6, VGR: Bone morphogenetic protein 6 precursor |
4.085 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
HTR2B |
HTR2B: 5-hydroxytryptamine receptor 2B |
4.085 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
MTMR3 |
MTMR3, KIAA0371, ZFYVE10: Myotubularin-related protein 3 |
4.085 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
4.085 |
Evidence |
|
| EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
THBS3 |
THBS3, TSP3: Thrombospondin-3 precursor |
4.085 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.085 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
4.085 |
Evidence |
|
| NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
PSD |
TYL: TYL protein |
4.08 |
Evidence |
|
| CD36 |
CD36, GP3B, GP4: Platelet glycoprotein 4 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
4.08 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
4.08 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
STX1A |
STX1A, STX1: Syntaxin-1A |
4.08 |
Evidence |
|